Office probing of congenital nasolacrimal duct obstruction

D. Stager, J. D. Baker, T. Frey, D. R. Weakley, E. E. Birch

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

We report the results of office nasolacrimal duct probing under topical anesthesia in 2369 eyes with symptomatic nasolacrimal duct obstruction. The overall success rate for cure by initial probing was 92%. In patients less than 9 months old, a 94% cure rate was achieved with one probing; in patients 9 months and older, the rate decreased to 84%. The decrease in success rate after 9 months was statistically significant (P < .00001 by chi-square analysis). A majority of 180 parents of these patients surveyed said they were happy with the office procedure and preferred having the probing performed to resolve symptoms, even though they realized that the symptoms most probably would resolve by 1 year of age without it. We conclude that office probing for congenital nasolacrimal duct obstruction is a safe and effective method for treatment of symptomatic nasolacrimal duct obstruction, allowing the cost and risk of general anesthesia as well as the cost and inconvenience of prolonged medical management to be avoided.

Original languageEnglish (US)
Pages (from-to)482-484
Number of pages3
JournalOphthalmic Surgery
Volume23
Issue number7
StatePublished - 1992

Fingerprint

Nasolacrimal Duct
Costs and Cost Analysis
General Anesthesia
Anesthesia
Parents

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Stager, D., Baker, J. D., Frey, T., Weakley, D. R., & Birch, E. E. (1992). Office probing of congenital nasolacrimal duct obstruction. Ophthalmic Surgery, 23(7), 482-484.

Office probing of congenital nasolacrimal duct obstruction. / Stager, D.; Baker, J. D.; Frey, T.; Weakley, D. R.; Birch, E. E.

In: Ophthalmic Surgery, Vol. 23, No. 7, 1992, p. 482-484.

Research output: Contribution to journalArticle

Stager, D, Baker, JD, Frey, T, Weakley, DR & Birch, EE 1992, 'Office probing of congenital nasolacrimal duct obstruction', Ophthalmic Surgery, vol. 23, no. 7, pp. 482-484.
Stager D, Baker JD, Frey T, Weakley DR, Birch EE. Office probing of congenital nasolacrimal duct obstruction. Ophthalmic Surgery. 1992;23(7):482-484.
Stager, D. ; Baker, J. D. ; Frey, T. ; Weakley, D. R. ; Birch, E. E. / Office probing of congenital nasolacrimal duct obstruction. In: Ophthalmic Surgery. 1992 ; Vol. 23, No. 7. pp. 482-484.
@article{dec5fb0a180b433ca29b812b2c226e86,
title = "Office probing of congenital nasolacrimal duct obstruction",
abstract = "We report the results of office nasolacrimal duct probing under topical anesthesia in 2369 eyes with symptomatic nasolacrimal duct obstruction. The overall success rate for cure by initial probing was 92{\%}. In patients less than 9 months old, a 94{\%} cure rate was achieved with one probing; in patients 9 months and older, the rate decreased to 84{\%}. The decrease in success rate after 9 months was statistically significant (P < .00001 by chi-square analysis). A majority of 180 parents of these patients surveyed said they were happy with the office procedure and preferred having the probing performed to resolve symptoms, even though they realized that the symptoms most probably would resolve by 1 year of age without it. We conclude that office probing for congenital nasolacrimal duct obstruction is a safe and effective method for treatment of symptomatic nasolacrimal duct obstruction, allowing the cost and risk of general anesthesia as well as the cost and inconvenience of prolonged medical management to be avoided.",
author = "D. Stager and Baker, {J. D.} and T. Frey and Weakley, {D. R.} and Birch, {E. E.}",
year = "1992",
language = "English (US)",
volume = "23",
pages = "482--484",
journal = "Ophthalmic Surgery Lasers and Imaging Retina",
issn = "2325-8160",
publisher = "Slack Incorporated",
number = "7",

}

TY - JOUR

T1 - Office probing of congenital nasolacrimal duct obstruction

AU - Stager, D.

AU - Baker, J. D.

AU - Frey, T.

AU - Weakley, D. R.

AU - Birch, E. E.

PY - 1992

Y1 - 1992

N2 - We report the results of office nasolacrimal duct probing under topical anesthesia in 2369 eyes with symptomatic nasolacrimal duct obstruction. The overall success rate for cure by initial probing was 92%. In patients less than 9 months old, a 94% cure rate was achieved with one probing; in patients 9 months and older, the rate decreased to 84%. The decrease in success rate after 9 months was statistically significant (P < .00001 by chi-square analysis). A majority of 180 parents of these patients surveyed said they were happy with the office procedure and preferred having the probing performed to resolve symptoms, even though they realized that the symptoms most probably would resolve by 1 year of age without it. We conclude that office probing for congenital nasolacrimal duct obstruction is a safe and effective method for treatment of symptomatic nasolacrimal duct obstruction, allowing the cost and risk of general anesthesia as well as the cost and inconvenience of prolonged medical management to be avoided.

AB - We report the results of office nasolacrimal duct probing under topical anesthesia in 2369 eyes with symptomatic nasolacrimal duct obstruction. The overall success rate for cure by initial probing was 92%. In patients less than 9 months old, a 94% cure rate was achieved with one probing; in patients 9 months and older, the rate decreased to 84%. The decrease in success rate after 9 months was statistically significant (P < .00001 by chi-square analysis). A majority of 180 parents of these patients surveyed said they were happy with the office procedure and preferred having the probing performed to resolve symptoms, even though they realized that the symptoms most probably would resolve by 1 year of age without it. We conclude that office probing for congenital nasolacrimal duct obstruction is a safe and effective method for treatment of symptomatic nasolacrimal duct obstruction, allowing the cost and risk of general anesthesia as well as the cost and inconvenience of prolonged medical management to be avoided.

UR - http://www.scopus.com/inward/record.url?scp=0026740198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026740198&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 482

EP - 484

JO - Ophthalmic Surgery Lasers and Imaging Retina

JF - Ophthalmic Surgery Lasers and Imaging Retina

SN - 2325-8160

IS - 7

ER -